189 related articles for article (PubMed ID: 18555688)
1. 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogs structurally modified by thiocarbamoylalkyl groups at the C-4 position: Synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.
Ikeda K; Sato K; Nishino R; Aoyama S; Suzuki T; Sato M
Bioorg Med Chem; 2008 Jul; 16(14):6783-8. PubMed ID: 18555688
[TBL] [Abstract][Full Text] [Related]
2. 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogues structurally modified at the C-4 position: synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.
Ikeda K; Sato K; Kitani S; Suzuki T; Maki N; Suzuki Y; Sato M
Bioorg Med Chem; 2006 Dec; 14(23):7893-7. PubMed ID: 16908163
[TBL] [Abstract][Full Text] [Related]
3. Syntheses of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified by N-sulfonylamidino groups at the C-4 position and biological evaluation as inhibitors of human parainfluenza virus type 1.
Nishino R; Ikeda K; Hayakawa T; Takahashi T; Suzuki T; Sato M
Bioorg Med Chem; 2011 Apr; 19(7):2418-27. PubMed ID: 21382718
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human parainfluenza virus type 1 sialidase by analogs of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid.
Suzuki T; Ikeda K; Koyama N; Hosokawa C; Kogure T; Takahashi T; Jwa Hidari KI; Miyamoto D; Tanaka K; Suzuki Y
Glycoconj J; 2001 Apr; 18(4):331-7. PubMed ID: 11788801
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of 4-O-alkylated 2-deoxy-2,3-didehydro-N-acetylneuraminic acid derivatives as inhibitors of human parainfluenza virus type-3 sialidase activity.
Tindal DJ; Dyason JC; Thomson RJ; Suzuki T; Ueyama H; Kuwahara Y; Maki N; Suzuki Y; von Itzstein M
Bioorg Med Chem Lett; 2007 Mar; 17(6):1655-8. PubMed ID: 17236768
[TBL] [Abstract][Full Text] [Related]
6. Syntheses of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified by α-acylaminoamido groups at the C-4 position using isocyanide-based four-component coupling and biological evaluation as inhibitors of human parainfluenza virus type 1.
Nishino R; Hayakawa T; Takahashi T; Suzuki T; Sato M; Ikeda K
Chem Pharm Bull (Tokyo); 2013; 61(1):69-74. PubMed ID: 23302587
[TBL] [Abstract][Full Text] [Related]
7. 2beta,3beta-Difluorosialic acid derivatives structurally modified at the C-4 position: synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.
Ikeda K; Kitani S; Sato K; Suzuki T; Hosokawa C; Suzuki Y; Tanaka K; Sato M
Carbohydr Res; 2004 May; 339(7):1367-72. PubMed ID: 15113676
[TBL] [Abstract][Full Text] [Related]
8. A single amino acid mutation at position 170 of human parainfluenza virus type 1 fusion glycoprotein induces obvious syncytium formation and caspase-3-dependent cell death.
Takaguchi M; Takahashi T; Hosokawa C; Ueyama H; Fukushima K; Hayakawa T; Itoh K; Ikeda K; Suzuki T
J Biochem; 2011 Feb; 149(2):191-202. PubMed ID: 21186250
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives.
Honda T; Yoshida S; Arai M; Masuda T; Yamashita M
Bioorg Med Chem Lett; 2002 Aug; 12(15):1929-32. PubMed ID: 12113811
[TBL] [Abstract][Full Text] [Related]
10. Design of N-acetyl-6-sulfo-beta-d-glucosaminide-based inhibitors of influenza virus sialidase.
Sasaki K; Nishida Y; Kambara M; Uzawa H; Takahashi T; Suzuki T; Suzuki Y; Kobayashi K
Bioorg Med Chem; 2004 Mar; 12(6):1367-75. PubMed ID: 15018909
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human neuraminidase 3 (NEU3) by C9-triazole derivatives of 2,3-didehydro-N-acetyl-neuraminic acid.
Zou Y; Albohy A; Sandbhor M; Cairo CW
Bioorg Med Chem Lett; 2010 Dec; 20(24):7529-33. PubMed ID: 21036040
[TBL] [Abstract][Full Text] [Related]
12. Exploring human parainfluenza virus type-1 hemagglutinin-neuraminidase as a target for inhibitor discovery.
El-Deeb IM; Guillon P; Winger M; Eveno T; Haselhorst T; Dyason JC; von Itzstein M
J Med Chem; 2014 Sep; 57(18):7613-23. PubMed ID: 25198831
[TBL] [Abstract][Full Text] [Related]
13. New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidase.
Chibanga VP; Dirr L; Guillon P; El-Deeb IM; Bailly B; Thomson RJ; von Itzstein M
Antiviral Res; 2019 Jul; 167():89-97. PubMed ID: 30951732
[TBL] [Abstract][Full Text] [Related]
14. Saturation transfer difference (STD) 1H-NMR experiments and in silico docking experiments to probe the binding of N-acetylneuraminic acid and derivatives to Vibrio cholerae sialidase.
Haselhorst T; Wilson JC; Thomson RJ; McAtamney S; Menting JG; Coppel RL; von Itzstein M
Proteins; 2004 Aug; 56(2):346-53. PubMed ID: 15211517
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of novel 3-C-alkylated-Neu5Ac2en derivatives as probes of influenza virus sialidase 150-loop flexibility.
Rudrawar S; Kerry PS; Rameix-Welti MA; Maggioni A; Dyason JC; Rose FJ; van der Werf S; Thomson RJ; Naffakh N; Russell RJ; von Itzstein M
Org Biomol Chem; 2012 Nov; 10(43):8628-39. PubMed ID: 22976385
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives.
Honda T; Masuda T; Yoshida S; Arai M; Kobayashi Y; Yamashita M
Bioorg Med Chem Lett; 2002 Aug; 12(15):1921-4. PubMed ID: 12113809
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1).
Magesh S; Moriya S; Suzuki T; Miyagi T; Ishida H; Kiso M
Bioorg Med Chem Lett; 2008 Jan; 18(2):532-7. PubMed ID: 18068975
[TBL] [Abstract][Full Text] [Related]
18. Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus.
Ryan C; Zaitsev V; Tindal DJ; Dyason JC; Thomson RJ; Alymova I; Portner A; von Itzstein M; Taylor G
Glycoconj J; 2006 Feb; 23(1-2):135-41. PubMed ID: 16575531
[TBL] [Abstract][Full Text] [Related]
19. Preparation of a fluorous protecting group and its application to the chemoenzymatic synthesis of sialidase inhibitor.
Ikeda K; Mori H; Sato M
Chem Commun (Camb); 2006 Aug; (29):3093-4. PubMed ID: 16855696
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified at the C-4 and C-9 positions and their behaviour towards sialidase from influenza virus and pig liver membrane.
Ikeda K; Sano K; Ito M; Saito M; Hidari K; Suzuki T; Suzuki Y; Tanaka K
Carbohydr Res; 2001 Jan; 330(1):31-41. PubMed ID: 11217960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
